These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 32594625)

  • 1. Continuous subcutaneous insulin infusion reduces maternal and neonatal risk in pregnant women with type 1 diabetes: An observational cohort study of 122 pregnancies.
    Dodesini AR; Cavalli G; Ciriello E; Lepore G; Corsi A; Scaranna C; Bellante R; Albizzi M; Galliani S; Mangili G; Trevisan R
    J Diabetes; 2020 Nov; 12(11):860-861. PubMed ID: 32594625
    [No Abstract]   [Full Text] [Related]  

  • 2. Continuous subcutaneous insulin infusion reduces neonatal risk in pregnant women with type 1 diabetes mellitus.
    Mantaj U; Gutaj P; Ozegowska K; Zawiejska A; Wroblewska-Seniuk K; Olejniczak D; Wender-Ozegowska E
    Ginekol Pol; 2019; 90(3):154-160. PubMed ID: 30950005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes control and pregnancy outcomes in women with type 1 diabetes treated during pregnancy with continuous subcutaneous insulin infusion or multiple daily insulin injections.
    Cypryk K; Kosiński M; Kamińska P; Kozdraj T; Lewiński A
    Pol Arch Med Wewn; 2008 Jun; 118(6):339-44. PubMed ID: 18619188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetes.
    Farrar D; Tuffnell DJ; West J
    Cochrane Database Syst Rev; 2007 Jul; (3):CD005542. PubMed ID: 17636806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin pump use compared with intravenous insulin during labour and delivery: the INSPIRED observational cohort study.
    Drever E; Tomlinson G; Bai AD; Feig DS
    Diabet Med; 2016 Sep; 33(9):1253-9. PubMed ID: 26927202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycemic, maternal and neonatal outcomes in women with type 1 diabetes using continuous glucose monitoring during pregnancy - Pump vs multiple daily injections, a secondary analysis of an observational cohort study.
    Kjölhede K; Berntorp K; Kristensen K; Katsarou A; Shaat N; Wiberg N; Knop FK; Kristensen L; Dotevall A; Elfvin A; Sandgren U; Sengpiel V; Englund-Ögge L
    Acta Obstet Gynecol Scand; 2021 May; 100(5):927-933. PubMed ID: 33176006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous subcutaneous insulin infusion preserves axonal function in type 1 diabetes mellitus.
    Kwai N; Arnold R; Poynten AM; Lin CS; Kiernan MC; Krishnan AV
    Diabetes Metab Res Rev; 2015 Feb; 31(2):175-82. PubMed ID: 25066412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous subcutaneous insulin infusion versus multiple daily injections in pregnant women with type 1 diabetes.
    González-Romero S; González-Molero I; Fernández-Abellán M; Domínguez-López ME; Ruiz-de-Adana S; Olveira G; Soriguer F
    Diabetes Technol Ther; 2010 Apr; 12(4):263-9. PubMed ID: 20210564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous subcutaneous insulin infusion in diabetes: patient populations, safety, efficacy, and pharmacoeconomics.
    Pozzilli P; Battelino T; Danne T; Hovorka R; Jarosz-Chobot P; Renard E
    Diabetes Metab Res Rev; 2016 Jan; 32(1):21-39. PubMed ID: 25865292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experiences of continuous subcutaneous insulin infusion in pregnant women with type 1 diabetes during delivery from four Italian centers: a retrospective observational study.
    Fresa R; Visalli N; Di Blasi V; Cavallaro V; Ansaldi E; Trifoglio O; Abbruzzese S; Bongiovanni M; Agrusta M; Napoli A
    Diabetes Technol Ther; 2013 Apr; 15(4):328-34. PubMed ID: 23537417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous subcutaneous insulin infusion vs multiple daily injections in pregnant women with type 1 diabetes mellitus: a systematic review and meta-analysis of randomised controlled trials and observational studies.
    Rys PM; Ludwig-Slomczynska AH; Cyganek K; Malecki MT
    Eur J Endocrinol; 2018 May; 178(5):545-563. PubMed ID: 29545258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type 1 diabetes control and pregnancy outcomes in women treated with continuous subcutaneous insulin infusion (CSII) or with insulin glargine and multiple daily injections of rapid-acting insulin analogues (glargine-MDI).
    Bruttomesso D; Bonomo M; Costa S; Dal Pos M; Di Cianni G; Pellicano F; Vitacolonna E; Dodesini AR; Tonutti L; Lapolla A; Di Benedetto A; Torlone E;
    Diabetes Metab; 2011 Nov; 37(5):426-31. PubMed ID: 21474360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous subcutaneous insulin infusion versus multiple daily injections: the impact of baseline A1c: response to Retnakaran et al.
    Blumer I
    Diabetes Care; 2005 Mar; 28(3):763; author reply 763-4. PubMed ID: 15735237
    [No Abstract]   [Full Text] [Related]  

  • 14. Continuous subcutaneous insulin infusion for managing diabetes: women's health implications.
    Hood DG
    Nurs Womens Health; 2012; 16(4):308-18. PubMed ID: 22900807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous subcutaneous insulin infusion (CSII) versus multiple daily injections (MDI) of rapid-acting insulin analogues and detemir in type 1 diabetic (T1D) pregnant women.
    Mello G; Biagioni S; Ottanelli S; Nardini C; Tredici Z; Serena C; Marchi L; Mecacci F
    J Matern Fetal Neonatal Med; 2015 Feb; 28(3):276-80. PubMed ID: 24724804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An observational 7-year study of continuous subcutaneous insulin infusion for the treatment of type 1 diabetes mellitus.
    Papargyri P; Ojeda Rodríguez S; Corrales Hernández JJ; Mories Álvarez MT; Recio Córdova JM; Delgado Gómez M; Sánchez Marcos AI; Iglesias López RA; Herrero Ruiz A; Beaulieu Oriol M; Miralles García JM
    Endocrinol Nutr; 2014 Mar; 61(3):141-6. PubMed ID: 24355548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous glucose monitoring for patients with type 1 diabetes on multiple daily injections of insulin: pros and cons.
    Maiorino MI; Petrizzo M; Bellastella G; Esposito K
    Endocrine; 2018 Jan; 59(1):62-65. PubMed ID: 28551774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Pregnant Type 1 Diabetes Patients with Continuous Subcutaneous Insulin Infusion: Tight Control Achieved with Unchanged Total Daily Insulin Dose Per Kilogram with Consecutive Basal/Prandial Insulin Ratio Adjustment.
    Baretić M; Lekšić G; Ivanišević M
    Diabetes Technol Ther; 2019 Nov; 21(11):675-676. PubMed ID: 31335202
    [No Abstract]   [Full Text] [Related]  

  • 19. New Design of a Percutaneous Port System for Continuous Intraperitoneal Insulin Infusion.
    Rieger C; Kurz K; Mueller-Hoffmann W; Gehr B; Liebl A
    J Diabetes Sci Technol; 2019 Nov; 13(6):1158-1160. PubMed ID: 31195815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetic Ketoacidosis Among Patients Treated With Continuous Subcutaneous Insulin Infusion.
    Dogan ADA; Jørgensen UL; Gjessing HJ
    J Diabetes Sci Technol; 2017 May; 11(3):631-632. PubMed ID: 27595713
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.